Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Common financial budgeting issues can disrupt your financial goals. Learn to identify and address these challenges for better budgeting.
19,311 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Duolingo built a global audience by offering free lessons and charging a devoted subset of users. As growth slows, in...
Warner Bros. Discovery and Paramount Global are exploring a merger that would fold HBO Max and Paramount+ into one pl...
Choosing a short-term bond ETF can feel tricky. This guide compares IGSB and VGSH on cost, yield, risk, and portfolio...
New data shows high-end metro areas are turning over listings faster than mid-priced markets, upending expectations a...
A tech sell-off can feel overwhelming, but it often creates value for patient buyers. This guide shows how to identif...
Tech names surged as AI infrastructure demand strengthens revenue outlook. This article breaks down what happened, wh...
This week, plug power stock rocketed about 20% as earnings and feasibility signals fed optimism about hydrogen adopti...
CryptoQuant's latest Exchange Leader ranks major crypto venues by reserve transparency, naming KuCoin as the most tra...
FuelCell Energy stock just dropped after a mixed Q1 2026 report. In this analysis, we break down the what, why, and w...
The White House confirmed the firing of a National Transportation Safety Board member amid misconduct allegations, wh...
Citi upgrades Intuitive Surgical to Buy as market volatility eases, with Stryker placed on a 90-day catalyst watch an...